News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
17
2023
-
07
Wu Bin, the former executive vice president of the China Pharmaceutical Business Association, and Li Yao, the president of Zhongkang Ruima Consulting Company, came to the company to share and exchange!
Classification：
News
In order to create a high-quality, all-round professional skills management talent team, on July 14, Shandong Keyuan Pharmaceutical Co., Ltd. (301281.SZ) and Shandong Linuo Pharmaceutical Co., Ltd. jointly formulated a training and learning plan for leaders. In particular, Wu Bin, the former executive vice president of the China Pharmaceutical Business Association, and Li Yao, the president of Zhongkang Ruima Consulting Company, were invited to give lectures in the company. Lun Lijun, chairman of Keyuan Pharmaceutical and Linuo Pharmaceutical, Jiang Hongsheng, general manager of Keyuan Pharmaceutical and Linuo Pharmaceutical, and all senior cadres participated in this training meeting.
President Wu said that "quality upgrade + technological drive + spiritual satisfaction" will become a lasting driving force for future industrial upgrading. In the next ten years, Chinese-style modernization and high-quality development of enterprises will complement each other. In the grand context of Chinese-style modernization, we will discuss and study the road to high-quality development of enterprises! The concept of transforming from treating diseases as the center to people's health as the center will lead the direction of medical policy in the next 10 years. In order to cope with the increasingly serious homogenization of market products, President Wu elaborated eight strategies. Then, Mr. Li explained to the participants the formulation and implementation of the brand strategy for chemical pharmaceutical companies, and the participants were deeply inspired.
Through this training and learning, the professional quality level of the management cadres of Keyuan Pharmaceutical and Linuo Pharmaceutical has been comprehensively improved, their professional knowledge has been enriched, and their professional knowledge and skills have been broadened. At the same time, through this activity, the in-depth integration between the parent company and subsidiaries has been greatly deepened, which is more conducive to the improvement of the advantages of "integration of raw materials and preparations", and has laid a solid foundation for the high-quality development of the two companies in the big health industry.
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China